Persist AI Analysis: $4M Raised

AI-driven services for drug formulation; revenue from seed funding and partnerships.

Persist AI primarily focuses on the pharmaceutical industry, specifically in the area of drug formulation discovery using robotics and artificial intelligence.

Persist AI operates in the drug formulation market, where it faces competition from several notable companies that also leverage artificial intelligence and robotics. Key competitors include:

1. Atomwise: Specializes in AI-driven drug discovery, focusing on small molecule drugs. Atomwise uses deep learning to predict the effectiveness of compounds, which can significantly speed up the drug discovery process.

2. Exscientia: This company is known for its AI-driven drug design platform that integrates machine learning with human expertise to optimize drug candidates. Exscientia claims to reduce the time taken for drug discovery significantly.

3. BenevolentAI: Focuses on using AI to enhance drug discovery and development processes. Their platform analyzes vast amounts of biomedical data to identify new drug candidates and therapeutic targets.

4. Recursion Pharmaceuticals: Utilizes AI and machine learning to automate the drug discovery process, particularly in rare diseases. Their approach combines biological data with advanced analytics to identify potential treatments.

5. Insilico Medicine: Known for its AI-driven drug discovery platform that accelerates the development of new drugs by predicting the efficacy and safety of compounds.

Notable differences and advantages:

• Speed and Efficiency: Many of these competitors, like Exscientia and Atomwise, emphasize their ability to significantly reduce the time required for drug discovery compared to traditional methods.
• Data Utilization: Companies like BenevolentAI and Insilico Medicine leverage extensive datasets to enhance their predictive capabilities, which can lead to more successful drug candidates.
• Focus Areas: While Persist AI focuses on drug formulation and delivery systems, competitors may have broader or different focuses, such as small molecules or specific disease areas.

• 2048 Ventures
• Innospark Ventures
• Fellows Fund
• YCombinator
• Pioneer Fund
• Good AI Capital
• Jovono
• National IT Industry Promotion Agency